Booth Andrew 4
4 · AbCellera Biologics Inc. · Filed Dec 10, 2021
Insider Transaction Report
Form 4
Booth Andrew
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Shares
2021-12-10$0.32/sh+500,000$160,000→ 553,500 total - Exercise/Conversion
Share Options (right to buy)
2021-12-10−500,000→ 5,384,820 totalExercise: $0.32From: 2020-03-23Exp: 2029-08-22→ Common Shares (500,000 underlying)
Holdings
- 130,959(indirect: By Spouse)
Common Shares